European Industrial Pharmacists Group

What European Industrial Pharmacists Group does

European Industrial Pharmacists Group (EIPG) is a non-profit professional association founded in 1966 and registered under French law (1901 law) with headquarters in Caen, France. It represents approximately 10,000 industrial pharmacists through 16 full national member associations across the EU and EEA, plus 3 observer states. EIPG provides a unified European voice for industrial pharmacists, engages with the European Commission, the European Medicines Agency (EMA), and other professional bodies such as EFPIA, EAHP, and PGEU on regulatory matters, and maintains formal recognition as an EMA-eligible industry stakeholder organization and EU Transparency Register participant.

EIPG's product portfolio is built around professional resources rather than commercial technology. Core deliverables include guidance documents (QP Code of Practice 2020, GDP Guidelines, CPD guidance for QPs and Regulatory Affairs, Good Regulatory Practice guide, transport-of-healthcare-products recommendations), educational programs (Annex 1 training course, webinars on AI in pharma and Pharmacist 5.0), position papers (Revised Pharmaceutical Legislation, Environmental Sustainability 2026), and participation in EU-funded consortia (PHAR-IN, PHARMINE, MOGLYNET). Digital infrastructure is limited to a website, member portal, social media presence, and webinar tooling. No proprietary software products, APIs, SDKs, or AI/ML capabilities are developed or sold.

Revenue is generated exclusively through membership dues paid by national member associations, with amounts set by the General Assembly proportional to the number of industrial pharmacists registered in each member organization. Specific fees, total revenue, headcount compensation, and financial statements are not publicly disclosed. Distribution is delivered through national association channels, the member-only website area, webinars, annual rotating General Assemblies, and the EIPG Awards Program (Past Presidents Award, Outstanding Service Award, President's Award, EIPG Fellowship, and Emerging Industrial Pharmacist Award).

Name

European Industrial Pharmacists Group

Legal name

European Industrial Pharmacists Group

Website

https://eipg.eu

Company type

Private

Founded year

1966

Operating status

Operating

Headcount range

1–10 employees

Short description

European Industrial Pharmacists Group (EIPG) is a non-profit association founded in 1966 representing approximately 10,000 industrial pharmacists across the EU/EEA through 16 national member associations. It provides regulatory engagement with the EMA and European Commission and delivers guidance documents, training, and position papers on pharmaceutical practice.

Ownership category

akta.pro rank

Product category

Professional Association Services (Pharmaceutical Industry)

SIC

International Affairs (9721)

akta.pro primary industry

Health, Pharmaceuticals & Medical Devices Regulatory Cooperation (BPADANAJ)

akta.pro secondary industry

Quality Assurance, GxP Compliance & Auditing FSP (HLAGAOAE)

Keywords

• Pharmaceutical professional association
• Industrial pharmacy representation
• Qualified person guidelines
• Pharmacy continuing education
• Pharmaceutical regulatory affairs

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Membership Fees: EIPG is a not-for-profit organization financed through contributions from national associations of Member States joining EIPG. Annual fees are payable by all Full Members and the amount is set by the General Assembly, proportional to the number of industrial pharmacists registered in the organization.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

EIPG is a pan-European non-profit professional association that represents industrial pharmacists through its national member associations, providing them with regulatory guidance documents, continuing professional development programmes, advocacy at EU institutions, and recognition awards. It functions as a coordinating umbrella body for the industrial pharmacy profession across the EU/EEA, engaging with the European Medicines Agency and other EU-level stakeholders on pharmaceutical legislation, GMP/GDP standards, and Qualified Person matters.

Product overview

EIPG is a professional association representing national professional organisations of pharmacists employed in the pharmaceutical or allied industries of EU Member States. Rather than offering a unified software product, EIPG provides a portfolio of professional resources including guidance documents on Good Distribution Practices, Qualified Person requirements, and regulatory affairs; educational programs including training courses on Annex 1 manufacturing requirements and collaborative doctoral projects (MOGLYNET, PHAR-IN, PHARMINE); position papers on pharmaceutical legislation and environmental sustainability; and an awards program recognizing leadership and service in industrial pharmacy.

Differentiator

Problem solved

Functional benefit

Products and services

• EIPG Membership for National Associations Annual membership programme for national associations of industrial pharmacists in EU/EEA countries, providing pan-European representation, access to EIPG guidance documents, and participation in working groups.
• EIPG Guidance Documents and Position Papers Proprietary regulatory guidance documents, position papers, and briefings on EU pharmaceutical legislation, GMP/GDP standards, Qualified Person requirements, and professional practice for industrial pharmacists.
• EIPG Continuing Professional Development Programmes Training and continuing professional development offerings, including webinars and educational events, for industrial pharmacists across EIPG member associations.
• EIPG-Roche Innovation Award Recognition award co-organised by EIPG and Roche honouring innovation by industrial pharmacists in Europe.
• EIPG Pharmacist of the Year Award Recognition award honouring an outstanding industrial pharmacist for contributions to the profession across Europe.

Quantifiable outcome

• Represents approximately 10,000 pharmacists across European pharmaceutical industry
• +1 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

14 partnerships are on record, tiered minor and core.

• MOGLYNET ConsortiumminorStrategic or Co-development Partner · 1 January 2013EIPG is a partner in Horizon 2020 MSCA joint doctoral project MOGLYNET - a multidisciplinary study on modulation of glycolytic flux for atherosclerosis treatment. EIPG assists in recruitment and training courses bridging university research and pharmaceutical industrial expectations.
• PHAR-IN ConsortiumcoreStrategic or Co-development Partner · 1 January 2013EIPG partners in PHAR-IN project (538252-LLP-1-2013-1-BE-ERASMUS-EKA) with pharmacy faculties and industrial partners to develop competence frameworks for industrial pharmacy practice in biotechnology.
• European CommissioncoreOthersEIPG maintains regular contacts with the European Commission. Meetings with their representatives are regularly organized. EIPG is also registered in the EU Transparency Register.
• European Medicines Agency (EMA)coreOthersEIPG is in contact with representatives of EMEA/EMA and is one of the Interested Parties with whom the agency may communicate and discuss matters of interest. EIPG is on the list of eligible industry stakeholder organizations recognized by EMA.
• European Federation of Pharmaceutical Industries and Associations (EFPIA)coreStrategic or Co-development PartnerEIPG maintains regular contact with EFPIA as one of the other European professional and trade associations which have a significant role in the pharmaceutical industry world.
• FIP (Fédération Internationale Pharmaceutique)minorStrategic or Co-development PartnerEIPG may liaise with FIP at an international level for matters of common interest.
• World Health Organization (WHO)minorStrategic or Co-development PartnerEIPG may liaise with WHO at an international level for matters of common interest.
• ISPE (International Society for Pharmaceutical Engineering)coreStrategic or Co-development PartnerEIPG collaborated with ISPE Italy to produce a whitepaper on 'Artificial Intelligence in Pharma: Empowering Industrial Pharmacists for the Digital Era' exploring AI-driven technologies in drug development, manufacturing, and regulatory processes.
• European Association of Faculties of Pharmacy (EAFP)coreStrategic or Co-development PartnerEIPG partners with EAFP through PHAR-IN project to propose competence frameworks for education in biotechnology for pharmaceutical industry employees.
• European Pharmaceutical Students Association (EPSA)minorStrategic or Co-development PartnerEIPG has collaborated with EPSA on educational events such as Autumn Assemblies covering topics like formulation of protein-based drugs.
• European Association of Hospital Pharmacists (EAHP)minorStrategic or Co-development PartnerEIPG maintains regular contact with EAHP for discussing issues of common interest as part of European pharmacy professional associations network.
• Pharmaceutical Group of the European Union (PGEU)minorStrategic or Co-development PartnerEIPG maintains regular contact with PGEU for discussing issues of common interest as part of European pharmacy professional associations network.
• Ordre National des Pharmaciens (France)minorStrategic or Co-development PartnerEIPG collaborated with Conseil Central B of the Ordre National des Pharmaciens on recommendations concerning transport of healthcare products under controlled temperature.
• PHARMINE ConsortiumcoreStrategic or Co-development PartnerEIPG participates in PHARMINE consortium with four universities (Brussels, Nancy, London, Lisbon) and pharmacy associations to develop bachelor/master/doctorate system for pharmacy education aligned with Bologna process.

Scale indicators5 records

Recent moves8 records

Expansion highlights6 records

Regional players

• American Society of Health-System Pharmacists (ASHP): The largest US association of pharmacy professionals. ASHP is a regional peer — a leading national pharmacy professional association analogous to EIPG but based in the US — and represents how EIPG's model scales within a single, large national market versus EIPG's pan-European coordination role.
• Royal Pharmaceutical Society (RPS): The UK professional body for pharmacists. RPS is a regional peer — a major national pharmacy professional association — and serves as EIPG's UK delegate (RPS Great Britain) within EIPG's own membership, but it operates primarily within UK rather than EU territory post-Brexit.

Broad incumbents

• European Federation of Pharmaceutical Industries and Associations (EFPIA): The largest European pharma industry trade association representing innovative drug manufacturers. EFPIA is a much larger, industry-funded peer organization operating in the same Brussels policy environment; EIPG engages with EFPIA on shared pharma-policy matters but represents professionals rather than companies.
• Drug Information Association (DIA): A global neutral, multidisciplinary membership association serving the life sciences R&D and regulatory ecosystem. DIA operates in adjacent territory to EIPG — pharmaceutical regulatory and scientific exchange — but with a global, product-development-wide remit rather than EIPG's European industrial-pharmacy specialty.

Direct peers

• International Society for Pharmaceutical Engineering (ISPE): A global not-for-profit association for pharmaceutical engineering and manufacturing professionals. EIPG and ISPE co-produced the AI-in-Pharma whitepaper, indicating active collaboration; ISPE is a direct peer in serving pharmaceutical manufacturing professionals and influencing GMP/regulatory practice.
• Pharmaceutical Group of the European Union (PGEU): The umbrella association representing community pharmacists in the EU. PGEU is a peer association in the European pharmacy-professional network; EIPG coordinates with PGEU on issues of common interest, and the two organizations cover complementary (community vs. industrial) pharmacy segments.
• Associazione Farmaceutici Industria (AFI): The Italian association of industrial pharmacists. AFI is a national-level direct peer to EIPG in mission, and EIPG leadership cooperates with SUPSI and Italian universities via AFI's network, making it a close functional and structural analogue.
• European Association of Hospital Pharmacists (EAHP): The European association representing hospital pharmacists across Europe. EAHP is structurally analogous to EIPG — a Brussels-facing professional association representing a pharmacy specialty — and EIPG maintains regular contact with EAHP on shared issues, making it a near-direct peer in the European pharmacy-association ecosystem.
• European Pharmaceutical Students Association (EPSA): The European umbrella for pharmacy students. EPSA is a generational-stage peer of EIPG — a European pharmacy association — and EIPG already collaborates with EPSA on educational events, making it a structurally similar pan-European pharmacy organization with a different (student) member base.
• Fédération Internationale Pharmaceutique (FIP): The global federation of national pharmacy associations and individual pharmacists. EIPG already liaises with FIP on international matters of common interest, making FIP the closest counterpart in mission and structure, though with a broader remit covering all pharmacy domains versus EIPG's industrial-pharmacy focus.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/eipgeu
• YouTubeyoutube.com/channel/UCud1xx01vM6T7luTlIIasFg
• Facebookfacebook.com/eurindpharm
• LinkedInlinkedin.com/company/european-industrial-pharmacists-group

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about European Industrial Pharmacists Group